• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
marei, M. (2021). A STUDY OF THE RELATION BETWEEN VITAMIN D AND PERIPHERAL NEUROPATHY IN EGYPTIAN MULTIPLE MYELOMA PATIENTS. ALEXMED ePosters, 3(2), 58-59. doi: 10.21608/alexpo.2021.75898.1161
muhamad yousuf marei. "A STUDY OF THE RELATION BETWEEN VITAMIN D AND PERIPHERAL NEUROPATHY IN EGYPTIAN MULTIPLE MYELOMA PATIENTS". ALEXMED ePosters, 3, 2, 2021, 58-59. doi: 10.21608/alexpo.2021.75898.1161
marei, M. (2021). 'A STUDY OF THE RELATION BETWEEN VITAMIN D AND PERIPHERAL NEUROPATHY IN EGYPTIAN MULTIPLE MYELOMA PATIENTS', ALEXMED ePosters, 3(2), pp. 58-59. doi: 10.21608/alexpo.2021.75898.1161
marei, M. A STUDY OF THE RELATION BETWEEN VITAMIN D AND PERIPHERAL NEUROPATHY IN EGYPTIAN MULTIPLE MYELOMA PATIENTS. ALEXMED ePosters, 2021; 3(2): 58-59. doi: 10.21608/alexpo.2021.75898.1161

A STUDY OF THE RELATION BETWEEN VITAMIN D AND PERIPHERAL NEUROPATHY IN EGYPTIAN MULTIPLE MYELOMA PATIENTS

Article 127, Volume 3, Issue 2, June 2021, Page 58-59  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.75898.1161
View on SCiNiTO View on SCiNiTO
Author
muhamad yousuf marei email
Hematology Department, Medical Research Institute, Alexandria University, Alexandria, Egypt
Abstract
Multiple myeloma (MM) is the second most frequent hematological malignancy and comprises about 1% of all cancers, and 10% of hematological malignancies.
Some of the agents used for treatment of MM may lead to peripheral neuropathy (PN) such as, thalidomide, bortezomib, and less commonly lenalidomide and carfilzomib.
PN is usually sensory neuropathy that may be accompanied by motor and autonomic neuropathy.
Vitamin D is known to decrease the possible damage to the peripheral nervous system.
Vitamin D has many essential functions in brain, including maintaining calcium balance and signaling, neurotrophic factors regulation, neuroprotection, neurotransmission modulation, and contributing to synaptic plasticity.
Vitamin D has important role in neuronal differentiation, maturation, through alterations in several neurotrophic factors, with increased synthesis of nerve growth factor (NGF), glial cell line–derived neurotrophic factor (GDNF), and neurotrophin 3 (NT-3), and with decreased synthesis of NT-4.
Serum levels of vitamin D have been inversely linked with painful symptoms and increased sensitivity to pain.
Keywords
Multiple myeloma (MM); Vitamin D; peripheral neuropathy (PN)
Supplementary Files
download 0058-1161 Presentation4-محول (1).pdf
download 0058-1161 Presentation4-محول (1).pdf
Statistics
Article View: 112
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.